These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1347185)

  • 1. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
    Morales JM; Andres A; Rodriguez Paternina E; Alcazar JM; Montoyo C; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):89-91. PubMed ID: 1347185
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal transplantation: nifedipine for the nonstarters? A prospective randomised study.
    Donnelly PK; Feehally J; Jurewicz A; Furness P; McCullough T; Harper SJ; Moorhouse J; Morgan J; Kehinde EO; Horsburgh T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):600-1. PubMed ID: 8438431
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
    Morales JM; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope LM; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2598-9. PubMed ID: 7940807
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
    Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
    Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 7. FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
    Offner G; Burdelski M; Hoyer PF; Winkler M; Brodehl J
    Transplant Proc; 1991 Dec; 23(6):3082-4. PubMed ID: 1721366
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
    Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
    Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
    Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
    Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
    Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin A; Stenzel KH
    Transplant Proc; 1996 Jun; 28(3):1309-10. PubMed ID: 8658672
    [No Abstract]   [Full Text] [Related]  

  • 12. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
    Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
    Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
    [No Abstract]   [Full Text] [Related]  

  • 13. Protocol biopsies in stable renal transplant patients under triple immunosuppression: results at 6 months.
    Rush DN; Jeffery JR; Gough J
    Transplant Proc; 1994 Oct; 26(5):2576. PubMed ID: 7940797
    [No Abstract]   [Full Text] [Related]  

  • 14. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of cyclosporine monitoring in blood by specific and nonspecific radioimmunoassay methods in renal transplant patients with stable renal function and nephrotoxicity.
    Sabaté I; Castelao AM; Santos P; Bover J; Martínez JM; Ruiz R; González de la Presa B; Moliner R; Palencia T; Griñó JM
    Transplant Proc; 1995 Aug; 27(4):2254-5. PubMed ID: 7652796
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
    Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
    Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril, an angiotensin converting enzyme inhibitor, on the massive proteinuria due to chronic rejection after renal transplantation--a prospective study.
    Morales JM; Andres A; Montoyo C; Praga M; Alcazar JM; Algranati L; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):92-3. PubMed ID: 1539354
    [No Abstract]   [Full Text] [Related]  

  • 19. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.